Last reviewed · How we verify
TMC125 once daily
TMC125 once daily is a Small molecule drug developed by St Stephens Aids Trust. It is currently in Phase 1 development.
At a glance
| Generic name | TMC125 once daily |
|---|---|
| Sponsor | St Stephens Aids Trust |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants (PHASE1)
- B-free Multistage Trial (PHASE4)
- Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I (PHASE3)
- Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)
- Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years (PHASE3)
- A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TMC125 once daily CI brief — competitive landscape report
- TMC125 once daily updates RSS · CI watch RSS
- St Stephens Aids Trust portfolio CI
Frequently asked questions about TMC125 once daily
What is TMC125 once daily?
TMC125 once daily is a Small molecule drug developed by St Stephens Aids Trust.
Who makes TMC125 once daily?
TMC125 once daily is developed by St Stephens Aids Trust (see full St Stephens Aids Trust pipeline at /company/st-stephens-aids-trust).
What development phase is TMC125 once daily in?
TMC125 once daily is in Phase 1.
Related
- Manufacturer: St Stephens Aids Trust — full pipeline
- Compare: TMC125 once daily vs similar drugs
- Pricing: TMC125 once daily cost, discount & access